請用此 Handle URI 來引用此文件:
http://tdr.lib.ntu.edu.tw/jspui/handle/123456789/40560
完整後設資料紀錄
DC 欄位 | 值 | 語言 |
---|---|---|
dc.contributor.advisor | 江文章 | |
dc.contributor.author | Lu-Chi Chan | en |
dc.contributor.author | 詹璐齊 | zh_TW |
dc.date.accessioned | 2021-06-14T16:51:20Z | - |
dc.date.available | 2011-08-06 | |
dc.date.copyright | 2008-08-06 | |
dc.date.issued | 2008 | |
dc.date.submitted | 2008-07-31 | |
dc.identifier.citation | 史宏、史關燕、楊成元、史根生、侯國亮、張翠萍、陳瑛。2007。小米的營養保健及食療價值的探討。雜糧作物 5: 10-15。
江文章。2000。健康飲食新主張。元氣齋出版社有限公司。pp. 106-107。 行政院衛生署。1998。台灣地區食品營養成分資料庫。行政院衛生署員生消費合作社。台北。 何菁菁。2000。糙薏仁對STZ所誘發之糖尿病大白鼠脂質與醣類代謝的影響。國立台灣海洋大學水產食品科學研究所碩士論文。基隆。 吳宜娟。2001a。薏仁加工產品對大白鼠脂質代謝之影響。國立台灣大學食品科技研究所碩士論文。台北。 吳明賢。2001b。破解潰瘍危險因子。常春月刊民國九十年七月號。pp. 36-38。 李煥榮、劉國柱、周正仁。1976。台灣藥用植物之探討(二)。國立中國醫藥研究所。台北。 林慧青。2007。餵食小米及薏仁加工產品在緊迫動物模式下對胃黏膜損傷與腸道酵素活性及血清鈣濃度之影響。國立台灣大學食品科技研究所碩士論文。台北。 島崎弘幸。1990。生體內過酸化脂質測定。過酸化脂質實驗法。醫藥齒科出版社。p.81。東京。 張成國。1997。食療與養生。元氣齋出版社有限公司。pp. 173-175。 莊淑旂。1977。健康法。主婦友社(株)。東京。 郭靜娟。2001。薏苡籽實之抗氧化成分及其抑制自由基傷害之研究。國立台灣大學食品科技研究所博士論文。台北。 陳正哲。1998。中草藥在抗氧化作用的測定。私立靜宜大學應用化學研究所碩士論文。台中。 陳國榮。2003。腎臟移植患者消化性潰瘍的危險因子--單一醫學中心十一年的經驗。私立中山醫學大學醫學研究所碩士論文。台中。 陳淑娟、尹彙文。2003。臨床營養學。合記圖書出版社。pp. 136-144。 陳麒仰。2002。中藥柴胡桂枝湯對大鼠急性胃損傷之預防的探討。國立台灣大學獸醫學研究所碩士論文。台北。 湯雅理。2000。飲食炸油與腎臟前列腺素E2合成。國立台灣大學農農業化學研究所博士論文。台北。 黃士禮、江文章。1999。薏苡籽實各部位之組成分及丙酮萃取液之抗突變作用。食品科學 26: 121-130。 黑瀨 巖。2005。消化系統的疾病與機制。世茂出版有限公司。pp. 78-79。 楊莉君、蔡敬民。1998。薏苡對倉鼠血漿脂質的影響。食品科學 25: 638-650。 劉伯康、陳惠英、顏國欽。1999。數種傳統食用植物甲醇萃取物抗氧化性之研究。中國農業化學會誌 37: 105-116。 蔡娟君。2004。國人檳榔、菸、酒使用與氣喘、心血管疾病、消化性潰瘍之相關性探討。私立高雄醫學大學口腔衛生科學研究所碩士論文。高雄。 蘇宗振。2001。國產精緻雜糧專櫃系列介紹(四),雜糧與畜產專題報導。pp. 25-26。 黨毅。1994。吃五榖更健康。元氣齋出版社有限公司。pp. 45-46。 Ahmad R, Moutairy AL, Mohammad T. 1996. Effect of vitamin E and selenium on hypothermic restraint stress and chemically-induced ulcers Dig Dis Sci 4: 1165-1171 Akoi M and Tuzihara N. 1984. Effects of the hatomugi (Coix lachrymal-jobi L. var. ma-yuen) on the blood pressure, cholesterol absorption and serum lipids levels. Kaseigaku Zasshi 35: 89-96. Alanko J, Riutta A, Holm P, Mucha I, Vappaatalo H, Metsaketela T. 1999. Modulation of arachidonic acid metabolism by phenols: relation to their structure and antioxidant prooxidant properties. Free Radic Biol Med 26: 193-201. Aldoori WH, Giovannucci EL, Stampfer MJ, Rimm EB, Wing AL, Willett WC. 1997. Prospective study of diet and risk of ulcer in men. Am J Epidemiol 145: 42-50. Appleyard CB, McCafferty DM, Tigley AW, Swain MG, Wallace JL. 1996. Tumor necrosis factor mediation of NSAID-induced gastric damage: role of leukocyte adherence. Am J Physiol 270: 42-48. Atay S, Tarnawski AS, Dubois A. 2000. Eicosanoids and the stomach. Prostaglandins Other Lipid Mediat 61: 105-124. Baptist NG and Perera BPM. 1956. Essential amino-acids of some tropical cereal millets. Br J Nutr 10: 334-337. Barrier CH and Hirschowitz BI. 1989. Controversies in the detection and management of nonsteroidal antiinflammatory drug-induced side effects of the upper gastrointestinal tract. Arthritis Rheum 32: 926-932. Bauer RF, Bianchi RG, BS J, Casler BS, Goldstin B. 1986. Comparative mucosal protective properties of misoprostol, cimetidine, and sucralfate. Dig Dis Sci 31: 81-85. Benjamim CF, Silva JS, Fortes ZB, Oliveira MA, Ferreira SH, Cunha FQ. 2002. Inhibition of leukocyte rolling by nitric oxide during sepsis leads to reduced migration of active microbicidal neutrophils. Infect Immunol 70: 3602-3610. Bhattacharya S, Banerjee D, Bauri AK, Chattopadhyay S, Bandyopadhyay SK. 2007. Healing property of the Piper betel phenol, allylpyrocatechol against indomethacin-induced stomach ulceration and mechanism of action. World J Gastroenterol 13: 3705-3713. Biswas K, Bandyopadhyay U, Chattopadhyay I, Varadaraj A, Ali E, Banerjee RK. 2003. A novel antioxidant and antiapoptotic role of omeprazole to block gastric ulcer through scavenging of hydroxyl radical. J Biol Chem 278: 10993-11001. Blandizzi C, Fornai M, Colucci R, Natale G, Lubrano V, Vassalle C, Antonioli L, Lazzeri G, Del Tacca M. 2005. Lansoprazole prevents experimental gastric injury induced by non-steroidal anti-inflammatory drugs through a reduction of mucosal oxidative damage. World J Gastroenterol 11: 4052- 4060. Boyd SC, Sasame HA, Boyd MR. 1979. High concentrations of glutathione in glandular stomach: Possible implication for carcinogenesis. Science 205: 1010-1012. Boyd SC, Sasame HA, Boyd MR. 1981. Gastric glutathione depletion and acute ulcerogenesis by diethylmaleate given subcutaneously to rats. Life Science 28: 2987-2992. Brzozowski T, Konturek PC, Konturek SJ. 2001. Effect of local application of growth factors on gastric ulcer healing and mucosal expression of cyclooxygenase-1 and cyclooxygenase-2. Digestion 64: 15-29. Brzozowski T, Konturek PC, Sliwowski Z, Drozdowicz D, Kwiecien S, Pawlik M, Pajdo R, Konturek SJ, Pawlik WW, Hahn EG. 2006. Neural aspects of ghrelin-induced gastroprotection against mucosal injury induced by noxious agents. J Physiol Pharmacol 6: 63-76. Brzozowski T. 2003. Experimental production of peptic ulcer, gastric damage and cancer models and their use in pathophysiological studies and pharmacological treatment--Polish achievements. J Physiol Pharmacol 3: 99-126. Chan FKL, Sung JJ, Chung SC. 1997. Randomised trial of eradication of Helicobacter pylori before non-steroidal anti-inflammatory drug therapy to prevent peptic ulcers. Lancet 350: 975-979. Chiang WC, Cheng CY, Chung KT. 2000. Effects of dehulled adlay on the culture count of some microbiota and their metabolism in the gastrointestinal tract of rats. J Agric Food Chem 48: 829-832. Chiba T, Sato K, Kudara N, Shinozaki H, Ikeda K, Sato K, Endo M, Orii S, Suzuki K. 2008. Upper gastrointestinal disorders induced by non-steroidal anti-inflammatory drugs. Inflammopharmacology 16: 16-20. Cho CH, Ko IK, Tang XL. 1994. The differential mechanism of mild irritants on adaptative cytoprotection. Eur J Gastroenterol Hepatol 9: 24-27. ChoI YY, Osada K, Ito Y, Nagasawa T, Choi MR, Nishizawa N. 2005. Effects of dietary protein of Korean foxtail millet on plasma adiponectin, HDL-cholesterol and insulin levels in genetically type 2 diabetic mice. Biosci Biotechnol Biochem 69: 31-37. Coffey RJ and Romano M. 1995. Roles for transforming growth factor α in the stomach. J Clin Gastroenterol 21: 36-39. Coffey RJ, Ganarosa LM, Damstrup L, Dempsey PJ. 1995. Basic actions of transforming growth factoralpha and related peptides. Eur J Gastroenterol & Hepatol 7: 923-927. Corne SJ, Morrissey SM, Woods RJ. 1974. A method for the quantitative estimation of gastric barrier mucus. Am J Physiol 242: 116-117. Crampton JR, Gibbons LC, Rees W. 1987. Effects of sucralfate on gastroduodenal bicarbonate secretion and prostaglandin E2 metabolism. Am J Med 83: 14-18. Dajani EZ, Agrawal NM. 1995. Prevention of nonsteroidal anti-inflammatory drug-induced gastroduodenal ulcers: role of mucosal protective and gastric antisecretory drugs. Dig Dis 13: 48-61. Davenport HW. 1967. Salicylate damage to the gastric mucosal barrier. N Engl J Med 276: 1307-1312. Davenport HW. 1968. Destruction of the gastric mucosal barrier by detergents and urea. Gastroenterology 54: 175–180. Davenport HW. 1982. Physiology of the digestive tract. Chicago, Year Book Medical Publishers, pp. 140-141. Rotter JI. 1983. Peptic ulcer. In The principles and practice of Medical Genetics. Emery AEH and Rimoin DL (eds). New York, Churchill Livingstone, pp. 863-878. Davies NW, Longstreth J, Jamali F. 2001. Misoprostol therapeutics revisited. Pharmacotherapy 21: 60-73. Delco F, Michetti P, Beglinger C, Fried M, Szucs TD. 2004. Health care resource utilization and costs of NSAID-induced gastrointestinal toxicity. A population-based study in Switzerland. Digestion 69: 10-19. Deveney CW, Deveney KE. 1987. Zollinger-Ellison syndrome (gastrinoma): Current diagnosis and treatment. Surg Clin North Am 67: 411-422. Dhikav V, Singh S, Pande S, Chawla A, Anand KS. 2003. Nonsteroidal drug-induced gastrointestinal toxicity: Mechanisms and management. J Indian Clin Med 4: 315-322. Dooley CP, Cohen H, Fitzgibbons PL, Bauer M, Appleman MD, Perez-Perez GI, Blaser MJ. 1989. Prevalence of Helicobacter pylori infection and histologic gastritis in asymptomatic persons. N Engl J Med 321: 1562-1566. Eberhart CE and Dubois RN. 1995. Eicosanoids and the gastrointestinal tract. Gastroenterology 109: 285-301. Ehdoh K and Leung FW. 1994. Effects of smoking and nicotine on the gastric mucosa: A review of clinical and experimental evidence. Gastroenterology 107: 864-878. Elliott SN, Mcknigh W, Cirino G, Wallace JL. 1995. A nitric oxide-releasing nonsteroidal anti-inflammatory drug accelerates gastric ulcer healing in rats. Gastroenterology 109: 524-530. Fiore MSH. 1967. An atlas of human histology, Lea& Febiger: Philadelphia, p. 131. Forman D. 1991. Helicobacter pylori infection: a novel risk factor in the etiology of gastric cancer. J Natl Cancer Inst 83: 1702-1703. Friedman GD, Siegelaub AB, Seltzer CC. 1974. Cigarettes, alcohol, coffee and peptic ulcer. N Engl J Med 290: 469-473. Goodlad R, Madgwick A, Moffatt M. 1990. Prostaglandins and the dog stomach: effects of misoprostol on the proportion of mucosa to muscle and on the proportion of different epithelial cell types. Digestion 45: 212-216. Goodlad RA, Rancliffe B, Lee CY, Wright NA. 1995. Dietary fiber and the gastrointestinal tract: differing trophic effects on muscle and mucosa of the stomach, small intestine and colon. Eur J Clin Nutr 49: 178-181. Graham DY, Agrawal NM, Roth SH. 1988. Prevention of NSAID-induced gastric ulcer with misoprostol: multicentre, double-blind, placebo-controlled trial. Lancet 2: 1277-1280. Grant HW, Palmer KR, Kelly RW, Wilson NH, Misiervicz JJ. 1988. Dietary linoleic acid, gastric acid and prostaglandin secretion. Gastroenterology 94: 955-959. Guo JS, Cho CH, Wang WP, Shen XZ Cheng CL, Koo MW. 2003. Expression and activities of three inducible enzymes in the healing of gastric ulcers in rats. World J Gastroenterol 9: 1767-1771. Hatazawa R, Tanigami M, Izumi N, Kamei K, Tanaka A, Takeuchi K. 2007. Prostaglandin E2 stimulates VEGF expression in primary rat gastric fibroblasts through EP4 receptors. Inflammopharmacology 15: 214-217. Hawkey CJ, Karrasch JA, Szczepañski L, Walker DG, Barkun A, Swannell AJ, Yeomans ND. 1998. Omeprazole compared with misoprostol for ulcers associated with nonsteroidal antiinflammatory drugs. Omeprazole versus misoprostol for NSAID-induced ulcer management (OMNIUM) study group. N Engl J Med 338: 727-734. Hawkey CJ, Tulassay Z, Szczepanski L. 1998. Randomized controlled trial of Helicobacter pylori eradication in patients on nonsteroidal anti-inflammatory drugs: The HELP NSAIDs study. Helicobacter eradication for lesion prevention. Lancet 352: 1016-1021. Hawkey CJ. 2000. Nonsteroidal anti-infl ammatory drug gastropathy. Gastroenterology 119: 521-535. Hayllar J and Bjarnason I. 1995. NSAIDs, COX-2 inhibitors, and the gut. Lancet 346: 522-524. Hegde PS, Chandrakasan G, Chandra TS. 2002. Inhibition of collagen glacation and crosslinking in vitro by methanolic extracts of Finger millet (Eleusine coracana) and Kodo millet (Paspalum scrobiculatum). J Nutr Biochem 13: 517-521. Hegde PS, Rajasekaran NS, Chandra TS. 2005. Effects of the antioxidant properties of millet species on oxidative stress and glycemic status in alloxan-induced rats. Nutr research 25: 1109-1120. Herwaarden MA, Samson M, van Nispen CH, Mulder PG, Smouth AJ. 1999. The effect of Helicobacter pylori eradication on intragastric pH during dosing with lansoprasole or ranitidine. Aiment Pharmacol Ther 13: 731-740. Hirokawa K and Kawasaki H. 1995. Change in glutathione in gastric mucosa of gastric ulcer patients. Res Commun Mol Pathol Pharmacol 88: 163-176. Hirose H, Takeuchi K, Okabe S. 1991. Effect of indomethacin on gastric mucosal blood flow around acetic acid-induced gastric ulcers in rats. Gastroenterology 100: 1259-1265. Hiroshi Y, Junichi Y, Hiroshi F, Yoshinori T. 2007. Up-to-date information on gastric mucosal lesions from long-term NSAID therapy in orthopedic outpatients: a study using logistic regression analysis. J Orthop Sci 12: 341-346. Hirota M, Inoue M, Ando Y, Hirayama K, Morino Y, Sakamoto K, Mori K, Akagi M. 1989. Inhibiton of stress-induced gastric injury in the rat by glutathione. Gastroenterology 97: 853-859. Hoekstra WG. 1975. Biochemical function of selenium and its relation to vitamin E. Fed Proc 34: 2083-2089. Hogaboam CM, Befus AD, Wallace JL. 1993. Modulation of rat mast cell reactivity by IL-1β: divergent effects on nitric oxide and plateletactivating factor release.). Immunol. 151: 3767-3774. Hopkins RJ, Girardi LS, Turney EA. 1996. Relationship between Helicobacter pylori eradication and reduced duodenal and gastric ulcer recurrence; a review. Gastroenterology 110: 1244-1252. Huang JQ, Sridhar S, Hunt R. 2002. Role of Helicobacter pylori infection and non-steroidal anti-inflammatory drugs in peptic ulcer disease: a meta-analysis. Lancet 359: 14-20. Ibrahim A, Abdulqader A, Jaber S, Mohammed O, Syed R. 2007. Aqueous suspension of anise “Pimpinella anisum ” protects rats against chemically induced gastric ulcers. World J Gastroenterol 13: 1112-1118. Isenberg JI, Hogan DL, Selling JA, Koss MA. 1986. Duodenal bicarbonate secretion in humans. Role of prostaglandins. Dig Dis Sci 31: 130. Jan C. Becker, Wolfram Domschke & Thorsten Pohle. 2004. Current approaches to prevent NSAID-induced gastropathy -- COX selectivity and beyond. Br J Clin Pharmacol 58: 587-600. Jones JB and Bailey RT Jr. 1989. Misoprostol: a prostaglandin E1 analog with antisecretory and cytoprotective properties. DICP 23: 276-282. Jorgensen TG, Weis-Fogh US, Nielsen HH, Olesen HP. 1976. Salicylateand aspirin-induced uncoupling of oxidative phosphorylation in mitochondria isolated from the mucosal membrane of the stomach. Scand J Clin Lab Invest 36: 649-654. Jung CH, Jun CY, Lee S, Park CH, Cho K, Ko SG. 2006. Rhus verniciflua stokes extract: radical scavenging activities and protective effects on H2O2-induced cytotoxicity in macrophage RAW264.7 cell lines. Biological and Pharmaceutical Bulletin 29: 1603-1607. Kalantar J, Eslick GD, Talley NJ. 1999. Chronic gastritis and nonulcer dyspepsia. Curr Top Microbiol Immunol. 241: 31-45. Kargman S, Charleson S, Cartwright M. 1996. Characterization of prostaglandin G/H synthase 1 and 2 in rat, dog, monkey and human gastrointestinal tracts. Gastroenterology 111: 445-454. Kearney BY, Kenneny PWN, Keeling JJ, Keating, Louise, Margaret, Gibney MJ. 1989. Dietary intakes and adipose tissue levels of linoleic acid in peptic ulcer disease. Br J Nutr 62: 699-706. Kitahura T and Guth PH. 1987. Effect of aspirin plus hydrochloric acid on the gastric mucosal microcirculation. Gastroenterology 93: 810-817. Konturek PC, Brzozowski T, Konturek SJ, Ernst H, Drozdowicz D, Pajdo R. 1997. Expression of epidermal growth factor and transforming growth factor alpha during ulcer healing. Scand J Gastroenterol 32: 6-15. Konturek PC, Konturek SJ, Cześnikiewicz M, Płonka M, Bielański W. 2002. Interaction of Helicobacter pylori (Hp) and nonsteroidal anti-inflammatory drugs (NSAID) on gastric mucosa and risk of ulcerations. Med Sci Monit 8: 197-209. Konturek PC, Konturek SJ, Konturek JW. 1996. Gastric secretion and the pathogenesis of peptic ulcer in the Helicobacter pylori infection. J Physiol Pharmacol 47: 5-12. Konturek SJ, Brzozowski T, Piastucki I, Dembinski A, Dembinska-Kiec A. 1982. Role of locally generated prostaglandin in adaptive gastric cytoprotection. Dig Dis Sci 27: 967. Konturek SJ, Konturek PC, Brzozowski T, Konturek JW, Pawlik WW. 2005. From nerves and hormones to bacteria in the stomach: Nobel Prize for achievements in gastroenterology during last century. J Physiol Pharmacol 56: 507-530. Konturek SJ, Radecki T, Brzozowski T, Piastucki I, Dembiñska-Kieæ A, Gryglewski R. 1981. Prostaglandin E2 in gastric mucosa and its role in the prevention of ulcers induced by acetyl salicylic acid in cats. Digestion 21: 205-213. Kurata JH and Nogawa AN. 1997. Meta-analysis of risk factors for peptic ulcer: Nonsteroidal antiinflammatory drugs, Helicobacter pylori, and smoking. J Clin Gastroenterol 24: 2-17. La Casa C, Villegas I, Alarc′on de la Lastra C, Motilva V, Mart′ın MJ. 2000. Evidence for protective and antioxidant properties of rutin, a natural flavonoid, against ethanol-induced gastric lesions. J Ethnopharmacol 71: 153-157. Lakshmi KP and Sumathi S. 2002. Effect of consumption of finger millet on hyperglycemia in non-insulin dependent diabetes mellitus (NIDDM) subjects. Plant Food Hum Nutr 57: 205-213. Levenstein S, Ackerman S, Kiecolt-Glaser JK. 1999. Stress and peptic ulcer disease. JAMA 281: 10-11. Li DS, Raybould HE, Quintero E, Cuth PH. 1992. Cahcitonin gene-related peptide mediates the gastric hyperemic response to acid backdiffusion. Gastroenterology 102: 1124-1128. Lichtenberger LM. 1995. The hydrophobic barrier properties of gastrointestinal mucus. Annu Rev Physiol 57: 565-583. Lipkin M. 1987. Proliferation and differentiation of normal and diseased gastrointestinal cells. In Physiology of the gastrointestinal tract. LR Johnson (ed). New York, Raven Press, pp. 255-284. Lippe IT and Holzer P. 1992. Participation of endothelium-derived nitric oxide but not prostacyclin in the gastric mucosal hyperaemia due to acid back-diffusion. Br J Pharmacol 105: 708-714. Lukie BE, Forstner GG. 1972. Synthesis of intestinal glycoproteins. Incorporation of [1-14C] glucosamine. Biochimica et Biophysica Acta 261: 353-364. Lyu SY, Rhim JY, Park WB. 2005. Antiherpetic activities of flavonoids against herpes simplex virus type 1 (HSV-1) and type 2 (HSV-2) in vitro. Archives of Pharmacol Research 28: 1293-1301. Mahmoud M, Khattab, Mohamed Z, Gad, Dalaal A. 2001. Protective role of nitric oxide in indomethacin-induced gastric ulceration by a mechanism independent of gastric acid secretion. Pharmacol Res 43: 463-467. Malagelada JR, Ahlquist DA, Moore SC. 1986. Defects in prostaglandin synthesis and metabolism in ulcer disease. Dig Dis Sci 31: 20-27. Malaty H, Graham DY, Isaksson I. 2000. Are genetic influences on peptic ulcer dependent or independent of genetic influences for Helicobacter pylori infection? Arch Intern Med 160: 105-109. Manga HM, Brkic D, Marie DEP, Quetin-Leclercq J. 2004. In vivo anti-inflammatory activity of Alchornea cordifolia (Schumach. & Thonn.) Müll. Arg. (Euphorbiaceae). J Ethnopharmacol 92: 209-214. Marshall BJ, Warren JR. 1984. Unidentified curved bacilli in the stomach of patients with gastritis and peptic ulceration. Lancet 1: 1311-1315. Martel-Pelletier J, Lajeunesse D, Reboul P, Pelletier JP. 2003. Therapeutic role of dual inhibitors of 5-LOX and COX, selective and non-selective non-steroidal anti-inflammatory drugs. Ann Rheum Dis 62: 501-509. Masubuchi Y, Saito H, Horie T. 1998. Structural requirements for the hepatotoxicity of nonsteroidal anti-inflammatory drugs in isolated rat hepatocytes. J Pharmacol Exp Ther 287: 208-213. Matuda H, Pongpiriyadacha Y, Morikawa T, Kishi A, Kataoka S, Yoshikawa M. 2003. Protective effects of steroid saponins from Paris polyphylla var. yunnanensis on ethanol- or indomethacin-induced gastric mucosal lesions in rats: structural requirement for activity and mode of action. Bioorganic & Medicinal Chemistry Letters 13: 1101-1106. Mcalindon ME, Muller AF, Filipowicz B, Hawkey CJ. 1996. Effect of allopurinol, sulphasalazine, and vitamin C on aspirin induced gastroduodenal injury in human volunteers. Gut 38: 518-524. Missiry MA, Sayed IH, Othman AI. 2001. Protection by metal complexes with SOD-mimetic activity against oxidative gastric injury induced by indomethacin and ethanol in rats. Ann Clin Biochem 38: 694-700. Moshkowitz M, Konikoff FM, Peled Y, Santo M, Hallak A, Bujanover Y, Tiomny E, Gilat T. 1995. High Helicobacter pylori numbers are associated with low eradication rate after triple therapy. Gut 36: 845-847. Mulholland MW and Debas HT. 1987. Chroi duodenal and gastric ulcer. Surg Clin North 67: 689. Natio Y, Yoshikawa T, Yoshida N, Kondo M. 1998. Role of oxygen radical and lipid peroxidation in indomethacin-induced gastric mucosal injury. Dig Dis Sci 43: 30-34. Neufeld G, Tzafra C, Gengrinovitch S, Poltorak Z. 1999. Vascular endothelial growth factor (VEGF) and its receptors. FASEB J 13: 9-22. Nishizawa N, Sato D, Ito Y, Nagasawa T, Hatakeyama Y, Choi MR, Choi YY, Wei YM. 2002. Effects of dietary protein of Proso millet on liver injury induced by D-galactosamine in rats. Biosci Biotechnol Biochem 66: 92-96. Ohkawa H, Ohishi N, Yagi K. 1979. Assay for lipid peroxides in animal tissues by thiobarbitric acid reaction. Anal Biochem 95: 351-358. Pandian RS, Anuradha CV, Viswanathan P. 2002. Gastroprotective effect of fenugreek seeds (Trigonella foenum graecum) on experimental gastric ulcer in rats. J Ethnopharmacol 81: 393-397. Papich M. 1993. Antiulcer therapy. Vet Clin North Am Small Anim Pract 23: 497-511. Paula M, Jonathan B, Wallacw JL. 1991. Role of oxygen-derived free radicals in indomethacin-induced gastric injury. Am J Physiol Gastrointest Liver Physiol 261: 470-475. Penissi A and Piezzi R. 1999. Effect of dehydroelucidine aon mucus production. A quantitative study. Dig Dis Sci 44: 708-712. Penney AG, Andrews FJ, O B.rien PE. 1994. Effects of misoprostol on delayed ulcer healing induced by aspirin. Dig Dis Sci 39: 934-939. Peskar BM and Maricic N. 1998. Role of prostaglandins in gastroprotection. Dig Dis Sci 43: 23-29. Peskar BM. 1991. Role of leukotriene C4 in mucosal damage caused by necrotizing agents and indomethacin in the rat stomach. Gastroenterology 100: 619-626. Peters MN, Richardson CT. 1983. Stressful life events, acid hypersecretion, and ulcer disease. Gastroenterology 84: 114-119. Pihan G, Regillo C, Szabo S. 1987. Free radicals and lipid peroxidation in ethanol- or aspirin-induced gastric mucosal injury. Dig Dis Sci 32: 1395-1401. Podolsky DK. 1994. Peptide growth factors in the gastrointestinal tract. In Physiology of the gastrointestinal tract. LR Johnson (ed), New York, Raven Press, pp. 129-167. Porro GB, Halter F, Lazzaroni M. 1999. Peptic ulcer. In Gastroenterology and hepatology. Jeffers D and Bruno F (eds). McGraw-Hill CO, New York, pp. 167-180. Poynard T, Lemaire M, Agostini H. 1995. Meta-analysis of randomized clinical trials comparing lansoprazole with ranitidine or famotidine in the treatment of acute duodenal ulcer. Eur J Gastroenterol Hepatol 7: 661-665. Rachie KO. 1975. The millets:importance, utilization and outlook. India, Hyderabad, International Corp Research Institute for the semi-arid tropic, p. 256. Ramakrishnan K., Salinas RC. 2007. Peptic ulcer disease. Am Fam Physician 76: 1005-1013. Reeves PG. 1997. Components of the AIN-93 diet as improvements in the AIN-76A diet. J Nutr 127: 838-841. Robert A, Nezamis IE, Lancaster C, Davies IP, Field SO, Hanchar AJ. 1983. Mild irritant prevent gastric necrosis through adaptive cytoprotection mediated by prostaglandins. Am J Physiol 245: 113-116. Robert A. 1976. Antisecretory, antiulcer, cytoprotective and diarrheogenic properties of prostaglandins. Adv Prostaglandin Thromboxane Res 2: 507-520. Robert A. 1979. Cytoprotection by prostaglandin. Gastroenterology 77: 761-767. Robert A. 1981. Prostaglandins and the gastrointestinal tract. In Physiology of the Gastrointestinal Tract. LR Johnson (ed). New York, Raven Press, pp. 1407-1434. Rosalmeida MC, Saraiva LD, Grac, Barreto BI, Brega MV, Gondim FA, Rola FH, Santos AA. 2003. Sildenafil, a phosphodiesterase-5 inhibitor, delays gastric emptying and gastrointestinal transit of liquid in awake rats. Dig Dis Sci 48: 2064-2068. Rotter JI. 1983. Peptic ulcer. In The principles and practice of Medical Genetics. Emery AEH and Rimoin DL (eds). New York, Churchill Livingstone, pp. 863-878. Roy PK, Venzon DJ, Shojamanesh H. 2000. Zollinger-Ellison syndrome: Clinical presentation in 261 patients. Medicine 79: 379-411. Sayanti B, Susri R, Chaudhuri1, Subrata Ch, and Bandyopadhyay SK. 2007. Healing properties of some Indian medicinal plants against indomethacin-induced gastric ulceration of rats. J Clin Biochem Nutr 41: 106-114. Schneider EL. 1999. Aging in the Third Millennium. Sci 283: 796-797. Schoen RT and Vender RJ. 1989. Mechanisms of nonsteroidal anti-inflammatory drug-induced gastric damage. Am J Med 86: 449-458. Sedlak J and Lindsay RH. 1968. Estimation of total, protein-bound, and nonprotein sulfhydryl groups in tissue with Ellman reagent. Anal Biochem 25: 192-205. Sellers LA, Carroll NJ, Allen A. 1986. Misoprostol-induced increases in adherent gastric mucus thickness and luminal mucus output. Dig Dis Sci 31: 91-95. Silverstein FE, Graham DY, Senior JR. 1995. Misoprostol reduces serious gastrointestinal complications in patients with rheumatoid arthritis receiving nonsteroidal anti-inflammatory drugs: a randomized, doubleblind, placebo-control trial. Ann Intern Med 123: 241-249. Singh G, Ramey DR, Morfeld D, Shi H, Hatoum HT, Fries JF. 1996. Gastrointestinal tract complications of nonsteroidal anti-inflammatory drug treatment in rheumatoid arthritis. A prospective observational cohort study. Arch Intern Med 156: 1530- 1536. Singh G. 1998. Recent considerations in nonsteroidal anti-inflammatory drugs gastropathy. Am J Med 105: 31-38. Smalley WE, Ray WA, Daugherty JR. 1995. Nonsteroidal anti-infl ammatory drugs and the incidence of hospitalizations for peptic ulcer disease in elderly persons. Am J Epidemiol 141: 539-545. Smedfors B and Johansson C. 1986. Stimulation of duodenal bicarbonate secretioAn by misoprostol. Dig Dis Sci 3: 96-100. Stein HJ, Hinder RA, Oosthuizen NMJ. 1990. Gastric mucosal injury caused by hemorrhagic shock and reperfusion: Protection role of the antioxidant glutathione. Surgery 108: 467-474. Su JD. 1992. Investigation of antioxidative activity and tocopherol contents on Chinese crude drugs of fruits or seeds. Food Sci 19: 12-24. Takahachi M, Konno C, Hikino H. 1986. Isolation and hypoglycemic activity of coixan A, B, C, glycans of Coix lachrymal-jobi L. var. ma-yuen seed. Planta Med 52: 64-65. Takeuchi K, Ueshima K, Matsumoto J, Okabe S. 1992. Role of capsaicin-sensitive sensory nerves in acid-induced bicarbonate secretion in rat stomach. Dig Dis Sci 37: 737-743. Takeuchi K, Yagi K, Kato S, Ukawa H. 1997. Roles of prostaglandin E-receptor subtypes in gastric and duodenal bicarbonate secretion in rats. Gastroenterology 113: 1553-1559. Tortora GJ and Grabowski SR. 1996. Principles of Anatomy and Physiology. 8th ed. New York, HarperCollins. Tytgat GNJ. 2000. Ulcers and gastritis. Endoscopy 32: 108-117. Ueki S., Takeuchi K, Okabe S. 1988. Gastric motility is an important factor in the pathogenesis of indomethacin-induced gastric mucosal lesions in rats. Dig Dis Sci 33: 209-216. Urakawa T, Kumagai K, Azumi Y, Itoh A, Sano I, Saitoh Y. 1987. Experimental study on mechanism of onset of acute ulcer viewed from blood coagulation and activities of fibrinolysis after hepatectomy in liver cirrhosis. J Jpn Surg Soc 88: 727-730. Urisini F, Maiorino M, Valente M, Gregolin C. 1982. Purfication from pig liver of a protein which protects liposomes and biomembranes from peroxidative degradation and exhibits glutathione peroxidase activity on phosphatidylcholine hydroperoxides. Bichem Biophys Ata 710: 197-205. Uteshev NS, Pakhomova GV, Tveritneva LF, Lebedev AG, Matveev SB, Marchenko VV, Golikov PP. 1999. Lipid peroxidation and antioxidant system functions in patients with gastroduodenal ulcerous hemorrhages undergoing conservative and surgicsl treatment. Vestn Khir Im I I Grek 158: 24-26. Vane JR. 1971. Inhibition of prostaglandin synthesis as a mechanism of action for aspirin-like drugs. Nat New Biol 231: 232-235. Wahder CE, Thiemermann C, Vane JR. 1990. Endothelium-derived relaxing factor participates in the increased blood flow in response to pentagastrin in the rat stomach mucosa. Proc Biol Sci 241: 195-200. Wallace JL and Miller MJ. 2000. Nitric oxide in mucosal defense: a little goes a long way. Gastroenterology 119: 512-520. Wallace JL, Granger DN. 1996. The cellular and molecular basis of gastric mucosal defense. FASEB J 10: 731-740. Wallace JL. 2001. Pathogenesis of NSAID-induced gastroduodenal mucosal injury. Best Pract Res Clin Gastroenterol 15: 691-703. Wang JY, Hsieh JS, Huang TJ. 1997. Changes in rat gastric mucosal glycoproteins in portal hypertension. Eur Surg Res 29: 280-286. Watanabe T. 1987. A study of the gastric mucosal change in the liver damage. Jpn J Gastroenterol 84: 2649-2657. Wilson D, Quadros E, Rajapaksa T. 1986. Effects of misoprostol on gastric acid and mucus secretion in man. Dig Dis Sci 31: 126-129. Wolfe MM, Lichtenstein DR, Singh G. 1999. Gastrointestinal toxicity of nonsteroidal antiinfl ammatory drugs. N Engl J Med 340: 1888-1899. Wright NA. 1984. Role of mucosal cell renewal in mucosal protection in the gastrointestinal tract. In Mechanisms of mucosal protection in the upper gastrointestinal tract. Allen A, Felmstrom G, Ganer A (eds). New York, Raven Press, pp. 15-20. Yamada T, Specian RD, Granger DN, Gaginella TS, Grisham MD. 1991. Misoprostol attenuates acetic acid-induced increases in mucosal permeability and inflammation: role of blood flow. Am J Physiol Gastrointest Liver Physiol 261: 332-339. Yamasaki K, Ishiyama H, Imaizumi T, Kambe T, Yabuuchi Y. 1989. Effect of OPC-12759, a novel antiulcer agent, on chronic and acute experimental gastric ulcer, and gastric secretion in rats. Japan J Pharmacol 49: 441-448. Yoshikawa T, Miyagawa H, Yoshida N, Sugino S, Kondo M. 1986. Increase in lipid peroxidation in rat gastric mucosal lesions induced by water-immersion restraint stress(WIRS). J Clin Biochem Nutr 1: 271-277. Yoshikawa T, Natio Y, Kishi A, Tomii T, Kaneko T, Iinuma S, Ichikawa H, Yasuda M, Takahashi S, Kondo M. 1993. Role of active oxygen, lipid peroxidation , and antioxidants in the pathogenesis od gastric mucosal injury by indomethacin in rats. Gut 34: 732-737. | |
dc.identifier.uri | http://tdr.lib.ntu.edu.tw/jspui/handle/123456789/40560 | - |
dc.description.abstract | 臨床上非固醇類抗發炎藥物(non-steroidal anti-inflammatory drugs, NSAIDs)的使用常引起消化道系統副作用(如胃潰瘍),而NSAIDs主要抑制胃部環氧化酶(cyclooxygenase, COX)的作用,導致前列腺素合成量降低,繼而破壞了胃黏膜防禦及修補機制(如非蛋白質硫基化合物及黏液分泌不足等),造成胃酸、胃蛋白酶及藥物等攻擊力量相對增強而誘發潰瘍。本研究藉由indomethacin(一種NSAID)誘導大鼠急性胃黏膜損傷動物模式,探討小米及糙薏仁之預防性功效,並評估食材單獨及混合給予其效果之差異。結果顯示,攝食實驗飼料含10% 小米、30% 糙薏仁及40% 混合物(小米10%+糙薏仁30%)對於負控制組(純以indomethacin處理)皆能減少胃部潰瘍指數(保護率達61%、68%及80%),且可降低血液、胃及肝臟中脂質過氧化物含量,並提升胃部前列腺素E2濃度約四倍(保護率達14~16%),其中亦可見胃中非蛋白質硫基化合物具有增高之趨勢,且與正控制組(藥物misoprostol)之效應相當,另外小米及糙薏仁無論單獨或混合攝食,其間並無存在顯著性差異。依以上結果推測,小米及糙薏仁均能夠保護大鼠胃黏膜受到NSAIDs的破壞,機制可能是藉由減緩NSAID伴隨之氧化性傷害,以及避免PGE2過度消耗來維護胃部防禦性障壁,進而達到保護胃部之效果。
關鍵詞:小米、糙薏仁、非固醇類抗發炎藥物、急性胃黏膜損傷 | zh_TW |
dc.description.abstract | The use of non-steroidal anti-inflammatory drugs (NSAIDs) can be associated with severe adverse effects of the digestive system (e.g. gastric ulcer). The principle ulcerogenic action of NSAIDs appears to work through their systemic inhibition of the cyclooxygenase (COX) enzyme, which catalyzes the formation of prostaglandins (PG). As a consequence of PG reduction, mucosal defense and repair mechanisms, such as gastric NPSH or mucus, are suppressed. Due to suppressed mucosal protective system, the corresponding attack of gastric acid, pepsin and drugs are enhanced, which lead to gastric ulceration. The present study was to investigate the abilities of foxtail millet and dehulled adlay to prevent lesions in the stomach individually and in combination on indomethacin (a NSAID) -induced gastric mucosal injury in rats. The results of this study demonstrated that rats fed with three different diets containing 1)foxtail millet (10%), 2)dehulled adlay (30%) and 3)mixture of millet and adlay (40%, foxtail millet plus dehulled adlay, the ratio is 1:3) had lowered gastric ulcer index (protective potency were 61%, 68%, 80% respectively) , reduced levels of lipid peroxidation in blood, stomach and liver, and enhanced degree of gastric prostaglandin E2 synthesis in stomach by 4 times (protective potency ranged from 14~16%). A positive trend of NPSH production was also observed. All of the results were comparable to the effects of positive control misoprostol, however, there was no significant difference between these treatment groups. Our finding showed that foxtail millet and/or dehulled adlay prevented macroscopic or microscopic indomethacin-induced gastric damage by decreasing oxidative damage and reverting the depletion of PGE2 induced by indomethacin significantly. This study suggested the feasibility of using foxtail millet and/or dehulled adlay for protecting humans from digestive disorder (e.g. gastric ulcer).
Key words: foxtail millet, dehulled adlay, non-steroidal anti-inflammatory drugs (NSAIDs), acute gastric mucosal lesions | en |
dc.description.provenance | Made available in DSpace on 2021-06-14T16:51:20Z (GMT). No. of bitstreams: 1 ntu-97-R95641033-1.pdf: 3381366 bytes, checksum: 047b05600305a0ea5b23671f9d1b894f (MD5) Previous issue date: 2008 | en |
dc.description.tableofcontents | 中文摘要.........................................................................................................I
英文摘要........................................................................................................II 詞彙縮寫對照表..............................................................................................IV 目錄..............................................................................................................VI 表目錄...........................................................................................................IX 圖目錄............................................................................................................X 第一章 續論....................................................................................................1 1.1 前言........................................................................................................1 1.2 文獻回顧..................................................................................................2 1.2.1 胃潰瘍...............................................................................................2 1.2.1.1介紹...............................................................................................2 1.2.1.2相關危險因子..................................................................................5 1.2.1.3臨床症狀及營養學建議...................................................................11 1.2.1.4醫學治療.......................................................................................13 1.2.2 非固醇類抗發炎藥物(NSAIDs).............................................................15 1.2.2.1 NSAIDs簡介.................................................................................15 1.2.2.2 NSAIDs與胃潰瘍之相關性.............................................................16 1.2.3胃黏膜防禦機制..................................................................................19 1.2.3.1前言.............................................................................................19 1.2.3.2防禦性障壁...................................................................................19 1.2.3.3細胞自我保護機制..........................................................................20 1.2.3.4相關防禦性因子.............................................................................21 1.2.4薏苡..................................................................................................25 1.2.4.1薏苡簡介.......................................................................................25 1.2.4.2生理機能性研究.............................................................................27 1.2.5小米..................................................................................................28 1.2.5.1小米簡介.......................................................................................28 1.2.5.2營養保健及食療價值......................................................................28 1.2.6急性胃黏膜損傷模式...........................................................................32 1.2.6.1 NSAID誘導急性胃黏膜損傷模式簡介...............................................32 1.2.6.2 Misoprostol介紹..........................................................................33 1.3糙薏仁取代劑量之選定.............................................................................33 1.4研究動機與目的.......................................................................................35 第二章 餵食小米及糙薏仁在急性胃黏膜損傷動物模式下所造成之影響.................36 2.1前言.......................................................................................................36 2.2實驗架構.................................................................................................38 2.3材料與方法.............................................................................................39 2.3.1實驗動物............................................................................................39 2.3.2實驗材料............................................................................................39 2.3.2.1試驗樣品.......................................................................................39 2.3.2.2飼料配製.......................................................................................40 2.3.2.3儀器設備.......................................................................................43 2.3.2.4化學藥品.......................................................................................43 2.3.3實驗方法............................................................................................44 2.3.3.1動物分組.......................................................................................44 2.3.3.2 NSAID誘導急性胃黏膜損傷模式.....................................................44 2.3.3.3組織樣本收集與分析方法................................................................44 2.3.3.4統計分析.......................................................................................50 2.4結果.......................................................................................................51 2.4.1小米及糙薏仁對動物生長、攝食量及組織臟器之影響..............................51 2.4.2小米及糙薏仁對潰瘍指數變化之影響.....................................................51 2.4.3胃臟切片組織學觀察...........................................................................51 2.4.4小米及糙薏仁對胃、肝組織與血液相關生化值之影響..............................52 2.4.4.1血液脂質過氧化物含量...................................................................52 2.4.4.2胃黏膜脂質過氧化物含量................................................................52 2.4.4.3胃黏膜非蛋白質硫基化合物含量......................................................52 2.4.4.4肝臟非蛋白質硫基化合物含量.........................................................52 2.4.4.5肝臟脂質過氧化物含量...................................................................53 2.4.4.6胃黏膜前列腺素E2含量...................................................................53 2.4.4.7胃黏膜黏液含量.............................................................................53 2.5討論.......................................................................................................54 2.5.1小米及糙薏仁對動物生長、攝食量及組織臟器之影響..............................54 2.5.2小米及糙薏仁對動物胃黏膜抗氧化潛力之影響........................................54 2.5.3小米及糙薏仁對動物胃黏膜損傷之影響.................................................55 2.5.4小米及糙薏仁對動物胃黏膜防禦性因子之影響........................................56 2.5.5小米及糙薏仁中可能有效成分..............................................................56 2.6結論.......................................................................................................59 參考文獻.......................................................................................................69 附錄.............................................................................................................88 | |
dc.language.iso | zh-TW | |
dc.title | 小米與糙薏仁對非固醇類抗發炎藥物誘導大鼠急性胃黏膜損傷之保護效果 | zh_TW |
dc.title | Protective Effects of Foxtail Millet and Dehulled Adlay on a Nonsteroidal Anti-inflammatory Drug-induced Gastric Mucosal Injury in Rats | en |
dc.type | Thesis | |
dc.date.schoolyear | 96-2 | |
dc.description.degree | 碩士 | |
dc.contributor.oralexamcommittee | 潘子明,謝明哲,游若萩,江孟燦 | |
dc.subject.keyword | 小米,糙薏仁,非固醇類抗發炎藥物,急性胃黏膜損傷, | zh_TW |
dc.subject.keyword | foxtail millet,dehulled adlay,non-steroidal anti-inflammatory drugs (NSAIDs),acute gastric mucosal lesions, | en |
dc.relation.page | 113 | |
dc.rights.note | 有償授權 | |
dc.date.accepted | 2008-07-31 | |
dc.contributor.author-college | 生物資源暨農學院 | zh_TW |
dc.contributor.author-dept | 食品科技研究所 | zh_TW |
顯示於系所單位: | 食品科技研究所 |
文件中的檔案:
檔案 | 大小 | 格式 | |
---|---|---|---|
ntu-97-1.pdf 目前未授權公開取用 | 3.3 MB | Adobe PDF |
系統中的文件,除了特別指名其著作權條款之外,均受到著作權保護,並且保留所有的權利。